TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD

QQQ $ 431.01 $ 6.55 (1.54 %)

DIA $ 382.27 $ 1.39 (0.36 %)

SPY $ 508.26 $ 4.77 (0.95 %)

TLT $ 88.26 $ 0.46 (0.52 %)

GLD $ 216.60 $ 0.70 (0.32 %)

Previous Close

$ 13.81

Open

$ 13.42

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 13.37 - $ 13.98

52 Week Range

$ 7.09 - $ 14.47

Volume

10,278,701

Average Volume

Market Cap

15.48B

Beta (5Y Monthly)

$ 1.17

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	02-12-2024	12-31-2023	10-K
2	11-09-2023	09-30-2023	10-Q
3	08-02-2023	06-30-2023	10-Q
4	05-10-2023	03-31-2023	10-Q
5	02-10-2023	12-31-2022	10-K
6	11-03-2022	09-30-2022	10-Q
7	07-27-2022	06-30-2022	10-Q
8	05-03-2022	03-31-2022	10-Q
9	02-09-2022	12-31-2021	10-K
10	10-27-2021	09-30-2021	10-Q
11	07-28-2021	06-30-2021	10-Q
12	04-28-2021	03-31-2021	10-Q
13	02-10-2021	12-31-2020	10-K
14	11-05-2020	09-30-2020	10-Q
15	08-05-2020	06-30-2020	10-Q
16	05-07-2020	03-31-2020	10-Q
17	02-21-2020	12-31-2019	10-K
18	11-07-2019	09-30-2019	10-Q
19	08-07-2019	06-30-2019	10-Q
20	05-02-2019	03-31-2019	10-Q
21	02-19-2019	12-31-2018	10-K
22	11-01-2018	09-30-2018	10-Q
23	08-02-2018	06-30-2018	10-Q
24	05-03-2018	03-31-2018	10-Q
25	02-12-2018	12-31-2017	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

us-supreme-court-declines-to-hear-vanda-pharmaceuticals-case-regarding-invalidation-of-patents-for-its-sleep-disorder-drug-hetlioz

US Supreme Court Declines To Hear Vanda Ph...
04/22/2024 18:37:55

"Supreme Court denies review of Vanda Pharmaceuticals' patent revival attempt for Hetlioz sleep-disorder medication. Le...

'The U.S Supreme Court Has Reportedly Decl...
04/22/2024 16:05:31

https://finance.yahoo.com/news/1-u-supreme-court-rejects-153720025.htmlThe U.S. Supreme Court on Monday declined to hear a bid ...

Alvotech Inks Long-Term Agreement With A S...
04/19/2024 10:11:54

"This new partnership agreement supports our financial guidance and reflects Alvotech's strong commitment to increasing...

Teva Pharmaceuticals Decided That Canada W...
04/18/2024 20:09:37

-SEC Filing

Alvotech, Teva Announce US FDA Approval Of...
04/16/2024 21:33:05

Under the strategic partnership between Teva and Alvotech, Teva is responsible for the exclusive commercialization of SELARSDI ...

Teva's New Real-World Evidence Presented A...
04/16/2024 12:18:43

Almost 80% of patients with Huntington's disease (HD) chorea were able to achieve optimal dosing within four weeks with the...

Teva Announces Results From Phase 3 Study ...
04/11/2024 12:38:26

Reported Saturday, Teva Pharmaceuticals Pr...
04/08/2024 07:14:12

PK modeling data provide insights into potential dosing conversions and strategies for switching to UZEDY from a long-acting ...

UroGen Pharma Files Patent Infringement Ac...
04/03/2024 12:26:56

UroGen Pharma Ltd. (NASDAQ:URGN), a biotech company dedicated to developing and commercializing novel solutions that treat urot...

Clinical Collaboration Agreement between T...
04/01/2024 12:33:25

Collaboration combines Teva's expertise in respiratory technology development and Launch Therapeutics' innovative late-...

'Supreme Court Unlikely To Limit Access To...
03/26/2024 16:01:57

https://www.washingtonpost.com/politics/2024/03/26/abortion-pill-supreme-court-arguments-mifepristone/The Supreme Court on Tues...

cramer-isnt-knocking-this-pharma-firm-anymore-as-a-matter-of-fact-im-going-in

Cramer Isn't 'Knocking' This Pharma Firm A...
03/25/2024 13:05:49

Raymond James Financial, Inc. (NYSE: RJF) is now valued more highly than JPMorgan Chase & Co. (NYSE: JPM), according to J...

FTC Files Amicus Brief in Asthma Inhaler P...
03/22/2024 17:56:54

-Wall Street Journal

senator-bernie-sanders-applauds-gsks-move-to-cap-inhaler-costs-at-35-per-month

Senator Bernie Sanders Applauds GSK's Move...
03/21/2024 11:17:20

GSK caps asthma and COPD medicine costs at $35/month, effective Jan 1, 2025. Includes Advair, Breo, Ventolin. Follows AstraZene...

8 Analysts Assess Teva Pharmaceutical Indu...
03/08/2024 14:00:13

JP Morgan Upgrades Teva Pharmaceutical Ind...
03/08/2024 13:12:25

JP Morgan analyst Chris Schott upgrades Teva Pharmaceutical Indus (NYSE:TEVA) from Underweight to Neutral and announces $14 ...

'France becomes first country to explicitl...
03/04/2024 17:53:02

https://www.washingtonpost.com/world/2024/03/04/france-abortion-constitution/

why-freshpet-shares-are-trading-higher-by-around-15-here-are-other-stocks-moving-in-mondays-mid-day-session

Why Freshpet Shares Are Trading Higher By ...
02/26/2024 18:57:55

Shares of Freshpet, Inc. (NASDAQ: FRPT) gained 15.5% to $106.29 after the company reported better-than-expected fourth-quarter...

10-health-care-stocks-with-whale-alerts-in-todays-session

10 Health Care Stocks With Whale Alerts In...
02/26/2024 17:35:26

why-is-generic-drugs-player-teva-pharma-stock-trading-higher-today

Why Is Generic Drugs Player Teva Pharma St...
02/26/2024 13:48:24

FDA-approved Simlandi (adalimumab-ryvk): a high-concentration biosimilar to Humira for rheumatoid arthritis, psoriasis, and more.